Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use.

Journal of intensive care medicine

Gunther M, Witenko CJ, Prust M, Salerno D, Berger K.
PMID: 34286612
J Intensive Care Med. 2021 Jul 21;8850666211031494. doi: 10.1177/08850666211031494. Epub 2021 Jul 21.

BACKGROUND: Patients with a history of alcohol use disorder are at an increased risk of hematoma expansion following intracranial hemorrhage (ICH) due to the effects of alcohol on platelet aggregation. Desmopressin (DDAVP) improves platelet aggregation and may decrease hematoma...

Cite
Gunther M, Witenko CJ, Prust M, et al. The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use. J Intensive Care Med. 2021;8850666211031494doi: 10.1177/08850666211031494.
Gunther, M., Witenko, C. J., Prust, M., Salerno, D., & Berger, K. (2021). The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use. Journal of intensive care medicine, 8850666211031494. https://doi.org/10.1177/08850666211031494
Gunther, Michelle, et al. "The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use." Journal of intensive care medicine vol. (2021): 8850666211031494. doi: https://doi.org/10.1177/08850666211031494
Gunther M, Witenko CJ, Prust M, Salerno D, Berger K. The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use. J Intensive Care Med. 2021 Jul 21;8850666211031494. doi: 10.1177/08850666211031494. Epub 2021 Jul 21. PMID: 34286612.
Copy Download .nbib Format: NLM
Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19.

Journal of the American College of Clinical Pharmacy : JACCP

Dzierba AL, Pedone T, Patel MK, Ciolek A, Mehta M, Berger K, Ramos LG, Patel VD, Littlefield A, Chuich T, May HB, Muir J, Verkerk BS, Poon T, Der-Nigoghossian C, Nikolos P, Gunther M, Shah J, Witenko CJ.
PMID: 32838224
J Am Coll Clin Pharm. 2020 Aug 12; doi: 10.1002/jac5.1316. Epub 2020 Aug 12.

Beginning in March 2020, New York City began the fight against coronavirus disease 2019. Health care workers were faced with a disease that led to significant morbidity and mortality with no proven therapies. As hospitals became inundated with patients...

Cite
Dzierba AL, Pedone T, Patel MK, et al. Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. J Am Coll Clin Pharm. 2020;doi: 10.1002/jac5.1316.
Dzierba, A. L., Pedone, T., Patel, M. K., Ciolek, A., Mehta, M., Berger, K., Ramos, L. G., Patel, V. D., Littlefield, A., Chuich, T., May, H. B., Muir, J., Verkerk, B. S., Poon, T., Der-Nigoghossian, C., Nikolos, P., Gunther, M., Shah, J., & Witenko, C. J. (2020). Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. Journal of the American College of Clinical Pharmacy : JACCP, . https://doi.org/10.1002/jac5.1316
Dzierba, Amy L, et al. "Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19." Journal of the American College of Clinical Pharmacy : JACCP vol. (2020). doi: https://doi.org/10.1002/jac5.1316
Dzierba AL, Pedone T, Patel MK, Ciolek A, Mehta M, Berger K, Ramos LG, Patel VD, Littlefield A, Chuich T, May HB, Muir J, Verkerk BS, Poon T, Der-Nigoghossian C, Nikolos P, Gunther M, Shah J, Witenko CJ. Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. J Am Coll Clin Pharm. 2020 Aug 12; doi: 10.1002/jac5.1316. Epub 2020 Aug 12. PMID: 32838224; PMCID: PMC7436296.
Copy Download .nbib Format: NLM
Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain.

P & T : a peer-reviewed journal for formulary management

Witenko C, Moorman-Li R, Motycka C, Duane K, Hincapie-Castillo J, Leonard P, Valaer C.
PMID: 25050056
P T. 2014 Jun;39(6):427-35.

For patients with low back pain, skeletal muscle relaxants are often initiated after failure of first-line analgesics. However, these medications (reviewed in this article) are controversial alternatives that carry risks of adverse effects and increased cost.

Cite
Witenko C, Moorman-Li R, Motycka C, et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P T. 2014;39(6):427-35
Witenko, C., Moorman-Li, R., Motycka, C., Duane, K., Hincapie-Castillo, J., Leonard, P., & Valaer, C. (2014). Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P & T : a peer-reviewed journal for formulary management, 39(6), 427-35.
Witenko, Corey, et al. "Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain." P & T : a peer-reviewed journal for formulary management vol. 39,6 (2014): 427-35.
Witenko C, Moorman-Li R, Motycka C, Duane K, Hincapie-Castillo J, Leonard P, Valaer C. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P T. 2014 Jun;39(6):427-35. PMID: 25050056; PMCID: PMC4103716.
Copy Download .nbib Format: NLM
Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.

The Annals of pharmacotherapy

Witenko CJ, Littlefield AJ, Abedian S, An A, Barie PS, Berger K.
PMID: 34486409
Ann Pharmacother. 2021 Sep 05;10600280211043188. doi: 10.1177/10600280211043188. Epub 2021 Sep 05.

No abstract available.

Cite
Witenko CJ, Littlefield AJ, Abedian S, et al. Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. Ann Pharmacother. 2021;10600280211043188doi: 10.1177/10600280211043188.
Witenko, C. J., Littlefield, A. J., Abedian, S., An, A., Barie, P. S., & Berger, K. (2021). Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. The Annals of pharmacotherapy, 10600280211043188. https://doi.org/10.1177/10600280211043188
Witenko, Corey J, et al. "Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019." The Annals of pharmacotherapy vol. (2021): 10600280211043188. doi: https://doi.org/10.1177/10600280211043188
Witenko CJ, Littlefield AJ, Abedian S, An A, Barie PS, Berger K. Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. Ann Pharmacother. 2021 Sep 05;10600280211043188. doi: 10.1177/10600280211043188. Epub 2021 Sep 05. PMID: 34486409.
Copy Download .nbib Format: NLM
The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.

The Annals of pharmacotherapy

Witenko CJ, Littlefield AJ, Abedian S, An A, Barie PS, Berger K.
PMID: 33985368
Ann Pharmacother. 2022 Jan;56(1):5-15. doi: 10.1177/10600280211017315. Epub 2021 May 14.

BACKGROUND: Propofol is commonly used to achieve ventilator synchrony in critically ill patients with coronavirus disease 2019 (COVID-19), yet its safety in this patient population is unknown.OBJECTIVE: To evaluate the safety, in particular the incidence of hypertriglyceridemia, of continuous...

Cite
Witenko CJ, Littlefield AJ, Abedian S, et al. The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. Ann Pharmacother. 2021;56(1):5-15doi: 10.1177/10600280211017315.
Witenko, C. J., Littlefield, A. J., Abedian, S., An, A., Barie, P. S., & Berger, K. (2022). The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. The Annals of pharmacotherapy, 56(1), 5-15. https://doi.org/10.1177/10600280211017315
Witenko, Corey J, et al. "The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019." The Annals of pharmacotherapy vol. 56,1 (2022): 5-15. doi: https://doi.org/10.1177/10600280211017315
Witenko CJ, Littlefield AJ, Abedian S, An A, Barie PS, Berger K. The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. Ann Pharmacother. 2022 Jan;56(1):5-15. doi: 10.1177/10600280211017315. Epub 2021 May 14. PMID: 33985368; PMCID: PMC8127019.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries